Spyre Therapeutics, Inc.
← Back to SYRE Overview

Spyre Therapeutics, Inc. (SYRE)

Revenue & Top-Line Growth

Latest Revenue

$-

Financial Fundamentals

SYREQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-03-310.00B0.09B
2025-12-310.09B0.09B
2025-09-300.00B0.00B
2025-06-300.00B0.00B
2025-03-310.00B0.00B
2024-12-310.00B0.00B
2024-09-300.00B0.00B
2024-06-300.00B0.00B
2024-03-310.00B0.00B-40.9%
2023-12-310.00B0.00B-62.0%
2023-09-300.00B0.00B-81.8%
2023-06-300.00B+247.5%+10.1%0.00B-82.5%
2023-03-310.00B+17.9%-85.5%0.00B-94.2%
2022-12-310.00B-3.4%-95.4%0.00B-87.6%
2022-09-300.00B-72.2%-87.6%0.01B-61.5%
2022-06-300.00B-54.1%-95.4%0.01B-48.7%
2022-03-310.00B-62.6%0.02B
2021-12-310.00B+160.5%0.02B
2021-09-300.00B-89.8%0.02B
2021-06-300.01B0.01B
2021-03-310.00B0.00B
2020-12-310.00B0.00B
2020-09-300.00B0.00B
2020-06-300.00B0.00B
2020-03-310.00B0.00B
2019-12-310.00B0.00B
2019-09-300.00B0.00B
2019-06-300.00B0.00B
2019-03-310.00B0.00B-58.5%
2018-12-310.00B0.00B-25.3%
2018-09-300.00B0.01B+8.1%
2018-06-300.00B+57.5%+60.8%0.01B+36.5%
2018-03-310.00B+1.9%+53.8%0.01B+20.6%
2017-12-310.00B+17.5%+18.8%0.01B+12.4%
2017-09-300.00B-14.7%+9.7%0.00B+0.1%
2017-06-300.00B+50.6%+7.7%0.00B-0.7%
2017-03-310.00B-21.3%+14.3%0.00B-31.6%
2016-12-310.00B+8.5%-21.3%0.00B-23.9%
2016-09-300.00B-16.3%+7.1%0.00B+10.4%
2016-06-300.00B+59.8%-59.9%0.00B+42.7%
2016-03-310.00B-45.8%0.01B
2015-12-310.00B+47.7%0.01B
2015-09-300.00B-68.7%0.00B
2015-06-300.00B0.00B
2015-03-310.00B0.00B
2014-12-310.00B0.00B
2014-09-300.00B0.00B
2014-06-300.00B0.00B
2014-03-310.00B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20250.00B
20240.00B
20230.00B-62.0%
20220.00B-87.6%
20210.02B
20200.00B
20190.00B
20180.00B-25.3%
20170.01B+12.5%
20160.00B-23.9%
20150.01B
20140.00B